Xxxxxxxxxxx Xxxxxx. Name: Title: Xxxxxxxxxxx Xxxxxx Chief Executive Officer As used in this schedule, the following terms shall have the meanings indicated: Regulation D; Regulation S. Without limiting the foregoing, but for greater clarity in this Schedule, it means, subject to the exclusions from the definition of directed selling efforts contained in Regulation S, any activity undertaken for the purpose of, or that could reasonably be expected to have the effect of, conditioning the market in the United States for any of the Offered Units, and includes the placement of any advertisement in a publication with a general circulation in the United States that refers to the offering of any of the securities;
Xxxxxxxxxxx Xxxxxx xxans the bylaws of ChoicePoint in the form filed as an exhibit to the Form S-1 at the time it becomes effective.
Xxxxxxxxxxx Xxxxxx xxxxx xxx xxxxxx xxxx have been or should be, in accordance with GAAP, recorded as capitalized leases.
Examples of Xxxxxxxxxxx Xxxxxx in a sentence
Should You have any questions concerning this License Agreement, or if You desire to contact Symantec for any reason, please write to: (i) Symantec Enterprise Customer Care, 000 Xxxxxxxxxxxxx Xxx, Xxxxxxxxxxx, Xxxxxx 00000, U.S.A., (ii) Symantec Enterprise Customer Care Center, XX XXX 0000, Xxxxxx 00, Xxxxxxx, or (iii) Symantec Enterprise Customer Care, 0 Xxxxxx Xxx, North Ryde, NSW 2113, Australia.
Fax: (000) 000-0000 Xxxxx & Xxxxxxxxx LLP 0000 Xxxxxxxxxxx Xxxxxx, XX Xxxxx 0000 Xxxxxxxxxx, X.X. 00000 Attn: Xxxxxxx X.
The principal office of the Company shall be located at 1000 Xxxxxxxxxxx Xxxxxx, XX, Xxxxx 000, Xxxxxxxxxx, X.X. 00000 or such other place as the Manager may from time to time designate by notice to the Members.
The jurisdiction and venue for any disputes arising under, or any action brought to enforce (or otherwise relating to), the Plan will be exclusively in the courts in the State of Xxxxx Xxxxxxxx, Xxxxxx xx Xxxxxxxxxxx, Xxxxxx Xxxxxx of America, including the Federal Courts located therein (should Federal jurisdiction exist).
Xxxxxxx Xxxxxxxxx Fax: (000) 000-0000 Email: [Email Address] and Ropes & Xxxx LLP Three Xxxxxxxxxxx Xxxxxx Xxx Xxxxxxxxx, XX 00000-0000 Attention: Xxxxx X.
More Definitions of Xxxxxxxxxxx Xxxxxx
Xxxxxxxxxxx Xxxxxx. (Authorized Signature)
Xxxxxxxxxxx Xxxxxx. Address for Notice: Securities: Name: MC2 BUSINESS ADVISORS INC. Address for Notice: Securities: Name: XXXXX XXXX
Xxxxxxxxxxx Xxxxxx. Address for Notice: Securities: Name: ZACORP VENTURES INC.
Xxxxxxxxxxx Xxxxxx. As to any date of determination, the aggregate Principal Balance of the Mortgage Loans that are (a) 60 or more days delinquent or (b) in bankruptcy or foreclosure and REO Properties.
Xxxxxxxxxxx Xxxxxx. By: Name: Title: Xxxxxxxxxxx Xxxxxx Chief Executive Officer Research Capital Corporation 000 Xxx Xxxxxx, Xxxxx 0000 Xxxxxxxx Xxxxx Xxxx, Xxx 000 Xxxxxxx, Xxxxxxx X0X 0X0 Ladies & Gentlemen: Reference is made to an agency agreement dated June 28, 2022 (the “Agency Agreement”) among Research Capital Corporation (the “Agent”) and Algernon Pharmaceuticals Inc. (the “Company”), relating to the sale, on an commercially reasonable “best efforts” basis, of up to 533,333 units (“Units”) in the capital of the Company, at a purchase price of $3.75 per Unit in the capital of the Company, for aggregate gross proceeds of up to approximately $2,000,000 (the “Offering”). The undersigned is an executive officer or director of the Company who holds Class A common shares (“Common Shares”) or securities convertible into, exchangeable for, or otherwise exercisable to acquire Common Shares or other securities of the Company (collectively, the “Locked-Up Securities”) and, accordingly, recognizes that the Offering will benefit the Company. The undersigned has good and marketable title to the Locked-Up Securities and acknowledges that the Agent is relying on the representations and agreements of the undersigned contained in this Lock-Up Agreement in carrying out and completing the Offering. In consideration of the foregoing, the undersigned hereby agrees that during the period commencing on June 28, 2022 and ending ninety (90) days after the date of closing of the Offering (the “Lock-Up Period”), the undersigned will not, directly or indirectly, offer, sell, contract to sell, lend, swap, or enter into any other agreement to transfer the economic consequences of, or otherwise dispose of or deal with, or publicly announce any intention to offer, sell, contract to sell, grant or sell any option to purchase, hypothecate, pledge, transfer, assign, purchase any option or contract to sell, lend, swap, or enter into any agreement to transfer the economic consequences of, or otherwise dispose of or deal with, whether through the facilities of a stock exchange, by private placement or otherwise, or announce any intention to do any of the foregoing, any Locked-Up Securities, directly or indirectly, without the prior written consent of the Agent, such consent not to be unreasonably withheld or delayed, provided that the Agent’s consent shall not be required in connection with (a) the exercise of previously issued options or other convertible securities, (b) transfers among a shareholder’s aff...
Xxxxxxxxxxx Xxxxxx. For any Loan Group consisting of Group III-VII Loans, and on any date of determination, the excess of the aggregate Principal Balance of the related Group III-VII Loans over the aggregate Certificate Principal Balance of the related Group III-VII Senior Certificates.
Xxxxxxxxxxx Xxxxxx. Name: Xxxxx Xxxxxx Title: Director XXXXXXXXXXX XXXXXX “Xxxxxxxxxxx Xxxxxx” Signature of Shareholder XXXXXX XXXXXXX “Xxxxxx Xxxxxxx” Signature of Shareholder XXXXXX XXXXXX “Xxxxxx Xxxxxx” Signature of Shareholder XXXXXXX XXXXXXXXXXXX “Xxxxxxx Xxxxxxxxxxxx” Signature of Shareholder XXXXX XXXXXX “Xxxxx Xxxxxx” Signature of Shareholder XXXXXXXXX XXXX “Xxxxxxxxx Xxxx” Signature of Shareholder XXXXXX XXXX “Xxxxxx Xxxx” Signature of Shareholder XXXXXX XXXXXX “Xxxxxx Xxxxxx” Signature of Shareholder XXXXXXX XXXXX “Xxxxxxx Xxxxx” Signature of Shareholder XXXXXXXX XXXXXX “Xxxxxxxx Xxxxxx” Signature of Shareholder CAIRO XXXXX “Cairo Xxxxx” Signature of Shareholder Signature of Shareholder XXX XXXXXXXX “Xxx Xxxxxxxx” Signature of Shareholder XXXX XXXXXX “Xxxx Xxxxxxx” Signature of Shareholder XXXXXXXXXXX XXXXXX XXXXXXX XXXXXXXX “Xxxxx Xxxxxxxx” Signature of Shareholder XXXX-XXXX XXXXXX “Xxxx-Xxxx Xxxxxx” Signature of Shareholder XXXXX XXXXXXXXX “Xxxxx Xxxxxxxxx” Signature of Shareholder XXXXX XXXXXXXXX “Xxxxx Xxxxxxxxx” Signature of Shareholder XXXXXXX XXXXXXXX “Xxxxxxx Xxxxxxxx” Signature of Shareholder